首页 > 市场调查报告书 > 医疗设备

器官移植市场规模、份额和成长分析（按产品类型、应用、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898685

器官移植市场规模、份额和成长分析（按产品类型、应用、最终用途和地区划分）－2026-2033年产业预测

Transplantation Market Size, Share, and Growth Analysis, By Product Type (Tissue Products, Immunosuppressive Drugs), By Application (Organ Transplantation, Tissue Transplantation), By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球器官移植市场规模将达到 168.5 亿美元，到 2025 年将达到 183.5 亿美元，到 2033 年将达到 363 亿美元，预测期（2026-2033 年）的复合年增长率为 8.9%。

全球器官移植市场受人口老化和生活方式改变导致的器官衰竭和慢性疾病（包括肾衰竭、肝衰竭和心臟衰竭）盛行率上升的驱动。外科手术技术、免疫抑制剂和组织工程技术的进步显着提高了移植成功率，并改善了患者的预后。然而，手术复杂性、高昂的费用以及对专业医疗基础设施的需求等挑战限制了器官移植的普及。市场成长的机会包括开发创新技术，例如用于器官保存的机械灌注技术，以及副作用较少的新型免疫抑制剂。提高公众对器官捐赠的认识以及加强医疗机构间的策略合作，有助于解决器官短缺问题，促进更多人获得挽救生命的移植服务，并提高患者的生活品质。

全球移植市场驱动因素

末期肾功能衰竭、肝硬化、心臟衰竭和呼吸系统疾病等慢性病的日益普遍，显着推高了器官移植的需求。糖尿病及其併发症等疾病的显着增加，进一步推动了肾臟和胰臟移植的需求。随着越来越多的患者患有这些慢性病，医疗系统面临着扩大移植服务以满足其迫切需求的压力，这也推动了全球移植市场的成长。这项转变凸显了有效的器官移植在改善患者预后和应对医疗危机的重要角色。

限制全球移植市场的因素

全球器官移植市场面临严峻挑战，器官移植费用高昂，包括移植前评估、手术、术后照护、长期免疫抑制剂治疗等。这些经济负担给患者、医疗系统和保险公司都带来了沉重压力。此外，移植服务的保险覆盖范围和报销政策的限制，进一步加剧了这些关键手术的成本效益和可及性问题。这些因素共同抑制了整个移植市场的发展，导致许多患者无法获得所需的器官移植，儘管移植手术可能挽救他们的生命。

全球移植市场趋势

全球移植市场日益关注精准医疗，其目标是透过根据个别患者特征量身定制治疗方法来提高移植疗效。利用生物标记分析、基因检测和先进的诊断工具，医疗服务提供者可以优化免疫抑制治疗，从而改善患者的整体预后。这种向个人化的转变正在推动移植通讯协定的重组、相容性评估的加强以及移植后併发症管理的改进。随着医疗系统将精准医疗方法置于优先地位，预计行业相关人员将增加对创新技术和研究的投资，最终推动患者照护的进步并提高移植成功率。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

AbbVie Inc.（USA）
BioLife Solutions（USA）
Medtronic（USA）
Arthrex, Inc.（USA）
Zimmer Biomet（USA）
21st Century Medicine（USA）
Novartis AG（Switzerland）
Stryker（USA）
Teva Pharmaceutical Industries Ltd.（Israel）
Veloxis Pharmaceuticals, Inc.（USA）
TransMedics Inc.（USA）
Hoffmann-La Roche Ltd.（Switzerland）
Astellas Pharma Inc.（Japan）
Preservation Solutions, Inc.（USA）
OrganOx Limited（UK）
Terumo Corporation（Japan）
Transonic（USA）
Sanofi（France）
Pfizer Inc.（USA）
CareDx, Inc.（USA）

结论与建议

简介目录

Product Code: SQMIG35D2158

Global Transplantation Market size was valued at USD 16.85 Billion in 2024 and is poised to grow from USD 18.35 Billion in 2025 to USD 36.3 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The global transplantation market is driven by the rising prevalence of organ failure and chronic diseases such as kidney, liver, and heart conditions, fueled by aging populations and lifestyle changes. Technological advancements in surgical techniques, immunosuppressive medications, and tissue engineering have significantly improved transplant success rates, enhancing patient outcomes. However, challenges like the complexity of procedures, high costs, and the need for specialized healthcare infrastructure can limit access. Opportunities for market growth include innovative methods like machine perfusion for organ preservation and the development of novel immunosuppressive drugs with fewer side effects. Increased awareness of organ donation and strategic collaborations among healthcare organizations can address organ shortages, ensuring broader access to life-saving transplantation services and fostering improved quality of life for patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segments Analysis

Global Transplantation Market is segmented by Product Type, Application, End-Use and region. Based on Product Type, the market is segmented into Tissue Products, Immunosuppressive Drugs and Preservation Solutions. Based on Application, the market is segmented into Organ Transplantation and Tissue Transplantation. Based on End-Use, the market is segmented into Hospitals, Transplant Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplantation Market

The increasing prevalence of chronic illnesses, including end-stage renal disease, liver cirrhosis, heart failure, and respiratory disorders, is significantly driving the need for organ transplantation. A notable surge in conditions like diabetes and its associated complications has particularly intensified the demand for kidney and pancreas transplants. As more individuals face the challenges posed by these chronic diseases, healthcare systems are being compelled to expand their transplantation services to meet the urgent needs of patients, thereby fostering growth within the global transplantation market. This shift underscores the critical role of effective organ transplantation in enhancing patient outcomes and addressing the healthcare crisis.

Restraints in the Global Transplantation Market

The global transplantation market faces considerable challenges due to the high costs associated with organ transplants, which encompass pre-transplant assessments, surgical procedures, postoperative care, and long-term immunosuppressive medications. These financial demands create substantial burdens for patients, healthcare systems, and insurance companies. Additionally, the limitations in insurance coverage and reimbursement policies for transplantation services exacerbate issues related to affordability and access to these critical procedures. This combination of factors contributes to the overall restraint of the transplantation market, making it difficult for many individuals to obtain necessary organ transplants despite potential life-saving benefits.

Market Trends of the Global Transplantation Market

The global transplantation market is increasingly characterized by a growing emphasis on precision medicine, which seeks to enhance the efficacy of transplant therapies by tailoring them to individual patient profiles. By leveraging biomarker analysis, genetic testing, and sophisticated diagnostic tools, healthcare providers can optimize immunosuppressive treatments and improve overall patient outcomes. This shift towards personalization is reshaping transplantation protocols, enhancing compatibility assessments, and facilitating better management of post-transplant complications. As healthcare systems prioritize precision approaches, stakeholders across the industry are likely to invest in innovative technologies and research, ultimately driving advancements in patient care and increasing the success rates of transplant procedures.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Transplantation Market Size by Product Type & CAGR (2026-2033)

Market Overview
Tissue Products
Immunosuppressive Drugs
Preservation Solutions

Global Transplantation Market Size by Application & CAGR (2026-2033)

Market Overview
Organ Transplantation
Tissue Transplantation

Global Transplantation Market Size by End-Use & CAGR (2026-2033)

Market Overview
Hospitals
Transplant Centers
Others

Global Transplantation Market Size & CAGR (2026-2033)

North America (Product Type, Application, End-Use)
- US
- Canada
Europe (Product Type, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
21st Century Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veloxis Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TransMedics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Preservation Solutions, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OrganOx Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transonic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareDx, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments